Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Axitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 23 Kidney Neoplasms 9 Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Carcinoma 6 Melanoma 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Neoplasm Metastasis 3 Carcinoma, Hepatocellular 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Kidney Diseases 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Adenoid Cystic 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myelodysplastic Syndromes 1

Interventions

Pemetrexed 12 Cisplatin 11 pembrolizumab 8 Carboplatin 6 Ipilimumab 5 Nivolumab 4 LMB-100 4 durvalumab 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 spartalizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡